Novo Nordisk, Inc. v. Viatris Inc.
1:23-cv-00013
Overview
Parties
Defendant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
1 Attorneys ListedPerkins Coie LLP
District of Columbia, 700 13th Street NW
Viatris Inc. Operating Company
Represented By
1 Attorneys ListedPerkins Coie LLP
District of Columbia, 700 13th Street NW
Plaintiff
Novo Nordisk A/S NPE (Individual / Inventor)
Represented By
10 Attorneys ListedGroombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Schrader Companion Duff & Law, PLLC
401 Main Street, Wheeling, WV 26003
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Schrader Companion Duff & Law, PLLC
401 Main Street, Wheeling, WV 26003
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Novo Nordisk, Inc. Operating Company
Represented By
10 Attorneys ListedGroombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Schrader Companion Duff & Law, PLLC
401 Main Street, Wheeling, WV 26003
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Schrader Companion Duff & Law, PLLC
401 Main Street, Wheeling, WV 26003
Groombridge, Wu, Baughman & Stone LLP
565 Fifth Avenue, Suite 2900, New York, NY 10017
Court & Judges
Court
District Court, N.D. West Virginia (wvnd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S
Mylan Pharmaceuticals Inc. et al. v. Novo Nordisk A/S
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8129343
Acylated GLP-1 compounds
|
Filed: 2006-03-20
Issued: 2012-03-06
|
Active (4.0 yrs remaining)
+1722d PTA
Expires: 2030-12-06
|
|
|
US8536122
Acylated GLP-1 compounds
|
Filed: 2012-03-05
Issued: 2013-09-17
|
Active (5.3 yrs remaining)
Expires: 2032-03-05
|
|
|
US9764003
Use of long-acting GLP-1 peptides
|
Filed: 2013-06-21
Issued: 2017-09-19
|
Active (6.6 yrs remaining)
Expires: 2033-06-21
|
|
|
US10888605
GLP-1 compositions and uses thereof
|
Filed: 2020-01-28
Issued: 2021-01-12
|
Active (13.2 yrs remaining)
Expires: 2040-01-28
|
|
|
US11318191
GLP-1 compositions and uses thereof
|
Filed: 2021-02-17
Issued: 2022-05-03
|
Active (14.2 yrs remaining)
Expires: 2041-02-17
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+1722 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
21
Dispositive
0
Granted
0
Denied
1
Pending / Review
20
Motions by Category
Key Dispositive Motions & Rulings